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Abstract
We aimed to investigate physical activity (PA) and risk of different histological subtypes of lung cancer according to
smoking status and body mass index using repeated measurements in a large cohort of women in Norway. The study
sample for the multiple imputation analyses consisted of 86,499 and for the complete-case analysis 80,802 women.
Repeated measurements of PA level, smoking habits, weight, and height were available for 54,691 women (63.2%), who
were included in repeated measurement analyses combined with multiple imputation to address attrition. Cox proportional
hazards regression models were used to calculate hazard ratios with 95% confidence intervals. During a median follow-up
of 12.9 years, 866 cases of primary lung cancer were identified. We found an inverse association between PA and lung
cancer overall. The results were consistent from multiple imputed data analysis to complete-case analysis of PA and
possible confounders. We observed a similar trend for adenocarcinoma, but not for squamous cell or small cell carcinomas.
Our findings suggest a more pronounced association between lung cancer overall and PA levels in current and former
smokers, and in normal-weight and overweight participants with increasing PA levels. The potential of a modifiable
lifestyle factor as PA to reduce the risk of lung cancer independently of smoking status is important in public health.
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Introduction
Lung cancer incidence has been increasing among women
worldwide and in Norway [1–3]. In Norway, it is the third
most common cancer among women, accounting for 10%
of all cancers, with 1465 new cases diagnosed in 2016 [3].
Lung cancer is one of the most incurable cancers due to
late presentation and disease recurrence with high fatality
[4]. Five-year relative survival for lung cancer is low and
was 22.0% for Norwegian women in 2012–2016 [3].
Smokers are 14 times more likely to develop lung
cancer compared to non-smokers [5]. However, not all
smokers develop lung cancer, suggesting individual vari-
ability in susceptibility to smoke-related respiratory car-
cinogens [5]. It is questioned if the increasing incidence in
women compared to men is a result of smoking patterns
and more susceptibility in developing lung cancer [1, 6]. In
a recent study of almost 300,000 Norwegian women find-
ings showed that given the same lifetime exposure women
had an increased susceptibility to lung cancer compared to
men [7]. Likewise, in a recently published study form the
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United States, they found a higher incidence of lung cancer
among young women compared with young men, which
are not fully explained by sex differences in smoking
behavior [8]. Therefore it is important to investigate whe-
ther a modifiable lifestyle factor as physical activity
potentially can reduce the risk of lung cancer among
women according to smoking habits. Furthermore, there is
evidence that increasing body mass index (BMI) is a pro-
tective factor against lung cancer [9]. In 2002, the Inter-
national Agency of Research in Cancer concluded that the
association between physical activity (PA) and risk of lung
cancer remained inconclusive [10]. In the World Cancer
Research Fund/American Institute for Cancer Research
(WCRF/AICR) report from 2007 to 2018, the evidence for
a protective effect of PA on lung cancer was categorized as
limited [11, 12]. However, in the years that followed,
several meta-analyses concluded that there was an associ-
ation between recreational PA and a reduced risk of lung
cancer [5, 13–18]. Moreover, it has been suggested that the
association between PA and risk of lung cancer among
smokers is stronger in women than in men [5]. The WCRF/
AICR report included different domains of PA, but few
studies have investigated both baseline and repeated mea-
surements of PA and other lifestyle factors [11].
It is still unclear whether the association between PA
and lung cancer is the result of an underestimation of
lifetime smoking; and therefore a better understanding of
this association in never smokers is needed. Indeed, few
studies to-date have investigated the association between
PA and lung cancer in never smokers, and those that did
found no statistically significant association [19–23].
We aimed to investigate PA and risk of different his-
tological subtypes of lung cancer according to smoking
status and BMI using repeated measurements of PA and
smoking status in a large cohort of women in Norway.
Methods
The Norwegian Women and Cancer Study
The Norwegian Women and Cancer (NOWAC) Study is a
nationally representative cohort study that has been
described in detail previously [24]. Briefly, random sam-
ples of Norwegian women aged 30–70 years were invited
to participate during three waves of data collection (1991/
1992, 1996/1997, and 2003/2004) [24, 25]. More than
172,000 women were enrolled in the study and completed a
questionnaire with detailed questions regarding lifestyle,
diet, and health, with an overall response rate of 52.7%.
The NOWAC Study was approved by the Regional Com-
mittee for Medical Research Ethics and the Norwegian
Data Inspectorate, and all participants included in the study
gave written informed consent.
In this analysis we used information from enrollment
questionnaires completed in 1996–2004 (baseline), and
from follow-up questionnaires completed 6–8 years after
enrollment (repeated measurement). In total 101,321
women completed baseline questionnaires and were eligi-
ble for inclusion in this study. We excluded women with
prevalent cancers other than non-melanoma skin cancer at
baseline (n = 4450), those who emigrated or died before
the start of follow-up (n = 13), and those who had missing
information on PA level (n = 9208) and smoking status
(n = 1151) at baseline. Thus, the final analytical study
sample for chained multiple imputation analyses consisted
of 86,499 women. For complete-case baseline and repeated
measurement analyses we further excluded women with
missing information in pack-years, height, weight, years of
education and fruit consumption (n = 5697). The final
analytical study sample for complete-case analyses con-
sisted of 80,802 women. Follow-up information on PA
level, smoking, weight, and height were available for
54,691 (63.2%) of these women, who were included in the
corresponding repeated measurements analyses.
Data collection
The description and validation of the assessment of PA in
the NOWAC Study have been described elsewhere [26].
Briefly, respondents reported their PA level in the
NOWAC questionnaire on a 10-point scale after reading
the following explanation: ‘‘By physical activity we mean
activity both at work and outside work, at home, as well as
training/exercise and other physical activity, such as
walking, etc. Please mark the number that best describes
your level of physical activity; 1 being very low and 10
being very high’’. The scale therefore reflects the amount
of PA across different domains, including recreational,
occupational, transportation, and household PA, and com-
bines them into one global PA level. This PA scale
appeared valid to rank PA level in Norwegian women, but
not to quantify a definite dose (i.e. frequency, duration and
intensity) of PA [26]. Information on the covariates height,
weight, years of education, alcohol consumption, fruit
consumption, vegetable consumption, menarche age,
menopausal status, number of children, hormone therapy
use and oral contraception use were taken from the
NOWAC questionnaire. Information on height and weight
was used to calculate BMI (kg/m2). Women also answered
questions on smoking status (never, former, or current),
duration, age at initiation and number of cigarettes smoked
per day. From this information number of pack-years was
calculated as number of cigarettes smoked per day divided
by 20 and multiplied by years of smoking at baseline and at
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follow-up. Women who reported that they were current or
former smokers at baseline and never smoker at follow-up
were categorized as former smokers at follow-up.
Women diagnosed with a primary, invasive, malignant
neoplasm of the lung (International Statistical Classifica-
tion of Diseases, Injuries and Causes of Death Revision 10
codes C33-34) [27] were identified through linkage to the
Cancer Registry of Norway, from which date of diagnosis
and morphology (International Classification of Diseases
for Oncology, 3rd edition) were also obtained. Based on
morphology, lung cancers were categorized into adeno-
carcinoma, squamous cell carcinoma, small cell carcinoma,
large cell carcinoma, other non-small cell carcinoma, and
other or not otherwise specified carcinoma. Here we pre-
sent data on the risk of lung cancer overall and on ade-
nocarcinoma, squamous cell carcinoma, and small cell
carcinoma, as they were the most frequent subtypes of lung
cancer. Information on date of death or emigration was
obtained through linkage to the Norwegian National Pop-
ulation Register.
Statistical methods
All the analyses and multiple imputations were done in
STATA version 14.0 (Stata Corp, College Station, TX,
USA).
We used the method proposed by Hu et al. [28], i.e.
baseline data was used until follow-up information became
available, death, or emigration, whichever occurred first.
Thereafter, follow-up information was applied until death,
emigration, or the end of the study period, whichever
occurred first. In the analysis using repeated PA measure-
ments, we also used follow-up information on BMI,
smoking status, and fruit consumption once it became
available. We used Cox proportional hazards regression
models to calculate hazard ratios (HRs) with 95% confi-
dence intervals (CIs) comparing five categories of PA level
(1–2, 3–4, 5–6, 7–8, and 9–10). PA level 5–6 was set as the
reference group. Follow-up time was defined as the interval
between age at baseline and age at cancer diagnosis, death,
emigration, or the end of follow-up (31 December 2014),
whichever came first.
Departures from the proportional hazards assumption in
the Cox models were tested through the inclusion of an
interaction variable between categories of PA level and
underlying time (age) [29]. A preliminary analysis of
baseline data was used to select the covariates [height
(meters), weight (kg), years of education, smoking status
(never, former, current), number of pack-years, alcohol
consumption (g/day), fruit consumption (g/day), veg-
etable consumption (g/day), menarche age (years), meno-
pausal status (pre, peri, postmenopausal), number of
children, hormone therapy use (yes/no) and oral
contraception use (yes/no)] for which we adjusted in the
models at complete-case analyses and imputed analyses.
The covariates that led to a change of at least 10% in the
PA regression coefficient were included in the final mod-
els: BMI (normal weight: \ 25, overweight: 25–29.9,
obese: C 30 kg/m2), years of education (B 9, 9–12,
C 13 years), smoking status in combination with pack-
years (never, former and pack-years \ 10, former and
pack-years C 10, current and pack-years\ 10 and current
and pack-years C 10, and fruit consumption (g/day) in
quartiles. In all the analysis models we stratified by birth
cohort (stratum 1: enrolled in 1996–1997 and born
1927–1942; stratum 2: enrolled in 1996–1997 and born
1943–1957; and stratum 3: enrolled in 2003–2007 and born
1943–1957). To test for linear trend, we used the original,
10-point PA scale, modelled as a continuous variable in the
analyses. Interactions between PA and the above-men-
tioned categories of BMI, years of education, and smoking
status were tested using likelihood ratio statistics.
In order to counteract residual confounding due to
smoking and BMI, we repeated our analyses in the strati-
fied samples by these two factors and with the same
adjustments as in the main models. In the stratified anal-
yses, PA levels 7–10 were collapsed both in baseline and
repeated measurements analyses due to the low number of
participants in the separate groups. In never smokers we
did not adjust for pack-years. We also conducted complete-
case baseline sensitivity analysis in which we considered
only information at cohort entrance [28].
Multiple imputation
Under the assumptions that data was missing at random, we
performed chained multiple imputation to deal with the
missing information at baseline and follow-up [30]. The
pattern of missing was confirmed arbitrary. We used a
similar imputation process as described in previous publi-
cations [31–33]. To reduce sampling variability, we created
20 replicate datasets from the imputation simulation [34].
We used separate imputation models for the outcomes lung
cancer overall and for each histological subtypes adeno-
carcinoma, squamous cell carcinoma, and small cell car-
cinoma, including all of the variables from the final
analysis; PA, smoking status and number of pack-years,
BMI and fruit consumption (baseline and follow-up
information) and education (baseline information). We
further included additional baseline variables in the
imputation process: age at smoking initiation, alcohol
consumption, number of children and menopausal status.
These variables were only used in the imputation process in
order to increase the predictive power of the imputation
procedure. The Nelson–Aalen cumulative hazard estimator
was included as a predictor in the imputation models [30].
Risk of lung cancer and physical activity by smoking status and body mass index, the… 491
123
The estimates from the 20 imputed datasets were combined
using Rubin’s rules [35].
Results
During more than 1.1 million person-years and a median
follow-up of 12.9 years, 866 cases of primary lung cancer
overall were identified. At baseline there were 353 (44.1%)
adenocarcinomas, 125 (14.4%) squamous cell carcinomas,
and 165 (18.1%) small cell carcinomas (Table 1). Other
histological subtypes represented 22% of the cases. Mean
age at cohort entrance was 51.7 years and the mean age at
lung cancer diagnosis was 64.4 years. At baseline, 43% of
the women reported a PA level of 5–6, and in total nearly
74.0% reported a PA level of 5 or higher. Sixty-one par-
ticipants (7%) later identified with lung cancer were never
smokers at baseline, whereas 665 (76.8%) were current
smokers. Women with a PA level of 5 or higher were more
frequently never smokers, had a lower BMI, and a higher
fruit and vegetable consumption than their counterparts
with lower PA levels (Table 1). Among 20,622 never
smoking women 1279 (6.25%) and 42 (0.34%) were for-
mer and current smokers at follow-up, respectively. Among
current smokers at baseline 3999 (19.5%) had stopped
smoking at follow-up. Women who dropped out of the
study were more often current smokers, but on average
they had PA levels that were similar to those of women
Table 1 Selected participant characteristics at study enrollment (baseline) in the Norwegian Women and Cancer study by physical activity (PA)
level (N = 86,499)
Characteristic PA level
1–2 3–4 5–6 7–8 9–10 Total
N = 4079 N = 19,005 N = 37,154 N = 21,819 N = 4442 N = 86,499
(4.7%) (22%) (43%) (25.2%) (5.1%) (100%)
Age (mean, ± SE) 53.2 (0.1) 52.2 (0.05) 51.5 (0.03) 51.3 (0.04) 51.9 (0.10) 51.7 (0.02)
Follow-up time years (mean, ± SE) 12.8 (0.07) 13.1 (0.03) 13.0 (0.02) 12.7 (0.03) 12.7 (0.06) 12.9 (0.01)
Lung cancer overall (n, %) 83 234 354 149 46 866 (100%)
Adenocarcinomaa (n, %) 26 114 154 67 21 382 (44.1%)
Squamous cell carcinomaa (n, %) 11 29 58 19 8 125 (14.4%)
Small cell carcinomaa (n, %) 22 37 65 32 9 165 (19.1%)
Other histological subtypesb (n, %) 24 54 77 31 8 194 (22%)
BMI (mean, ± SE)c 26.9 (0.09) 25.8 (0.03) 24.6 (0.02) 23.8 (0.02) 23.6 (0.05) 24.7 (0.01)
Years of education (mean, ± SE)d 11.4 (0.06) 12.1 (0.03) 12.3 (0.02) 12.6 (0.02) 11.8 (0.06) 12.3 (0.01)
Smoking status (%)e
Never 29.9 36.6 37.7 37.8 35.8 37
Former 30.2 31.7 33.2 35.5 33.5 33.3
\ 10 pack-years 66.1 74 77 77.8 79.8 76.3
C 10 pack-years 33.9 26 23 22.2 20.2 23.7
Current 39.9 31.8 29.2 26.7 30.7 29.7
\ 10 pack-years 22.9 23.7 27.8 26.6 32.2 27.2
C 10 pack-years 77.1 76.3 72.2 70.4 67.8 72.8
Pack-years of smoking in ever smokers (mean, ± SE) 13.6 (0.20) 11.3 (0.09) 10.0 (0.06) 9.4 (0.07) 9.5 (0.16) 10.3 (0.04)
Alcohol consumption, mean ± SE (g/day)f 3.6 (0.11) 3.6 (0.04) 3.5 (0.03) 3.7 (0.04) 3.4 (0.10) 3.6 (0.02)
Fruit consumption, mean ± SE (g/day) 166 (2.35) 185 (1.04) 204 (0.76) 225.2 (1.07) 240.4 (2.70) 205.2 (0.52)
Vegetable consumption, mean ± SE (g/day) 120.5 (1.4) 131.2 (0.62) 140.1 (0.45) 154.5 (0.65) 166.1 (1.7) 142.2 (0.31)
SE standard error, BMI body mass index
aHistological subtypes of lung cancer: only the main subtypes are included in the analysis
bOther histological subtypes: large cell, other non-small cell and other are not included in the analysis
cNumber of total missing in BMI 1567 (1.8%)
dNumber of total missing in years of education 4267 (4.9%)
eNumber of total missing in smoking status 1151 (1.4%)
fNumber of total missing in alcohol consumption 2095 (2.6%)
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who did not drop out of the study. There was four missing
observations in pack-years at baseline among former and
current smokers. The pattern of missing from baseline to
follow-up shows that 63.2% (54,691) of the participants
had information at follow-up for smoking status, weight,
and height. The proportion of missing at follow-up reported
in Table 2 shows that there was 41.8% missing in PA,
37.9% in BMI, 37.2% in smoking status and 42.1% in
pack-years (former and current smokers). However, the
missing is arbitrary and equally distributed as the complete
data over levels of PA (Table 2), by smoking status and
BMI groups (Supplementary Tables 3 and 4).
In the analysis using the imputed dataset and adjusted
models we observed that low PA level was negatively
associated with the risk of lung cancer overall (P for
trend = 0.000) (Table 3). Participants with a PA level of
1–2 had 73% increased risk of lung cancer overall com-
pared to those with PA levels of 5–6 (HR = 1.73; 95% CI
1.30–2.30). Participants with a PA level higher than 5–6
showed a tendency for a reduced risk of lung cancer overall
(HR for PA level 7–8 = 0.84; 95% CI 0.67–1.06 and HR
for PA level 9–10 = 0.87; 95% CI 0.57–1.32), however not
significant. The results for adenocarcinoma showed a
comparable statistically significant trend; but no significant
associations were found for any of the other investigated
histological subtypes (Table 3).
Interactions between PA and categories of BMI, smok-
ing status, and years of education were not significant (P
for trend = 0.87, P for trend = 0.42, and P for trend =
0.24, respectively). In spite of this, we investigated the
association between PA and risk of lung cancer overall in
analyses stratified by smoking status and BMI groups.
Analyses stratified by smoking status showed no significant
association between levels of PA and lung cancer overall in
never smokers. However, in former and current smokers
with PA levels 1–2 there was a significant, increased risk of
lung cancer overall (HR = 2.34, 95% CI 1.42–3.85 and
HR = 1.74, 95% CI 1.29–2.33, respectively), with a con-
sistent decreasing risk with increasing PA levels (Table 3).
Analyses stratified by BMI showed a higher risk of lung
cancer overall among normal-weight (HR = 1.60, 95% CI
1.12–2.28) for PA levels 1–2, and more pronounced for
overweight participants with PA levels 1–2 (HR = 2.37,
95% CI 1.54–3.63) (Table 3). No significant associations
were found for obese participants.
Complete-case analyses yielded similar results as the
imputed data analysis (Supplementary Table 2) in the main
analysis. However, the results for the analysis stratified by
smoking status was not statistically significant in former
smokers. Stratification for BMI yielded results similar to
those of imputed data analyses for normal-weight. For
overweight participants the association between PA levels
and lung cancer overall was not significant in the complete
case analysis (Supplementary Table 2).
Discussion
In this large Norwegian cohort, we found an inverse
association between self-reported PA level and risk of lung
cancer overall using chained multiple imputations. The
results were consistent when using complete-case analysis
baseline and repeated measurements of PA, BMI and
smoking status. We observed a similar trend for adeno-
carcinomas; however no statistically significant associa-
tions were found for squamous cell carcinoma or small cell
carcinoma. Our findings further suggest a more pronounced
association between lung cancer overall and PA levels in
former and current smokers, with an increased risk corre-
sponding to low levels of PA, whereas no significant
associations were found in never smokers. We found a
Table 2 Distribution of missing information (%) by physical activity level at baseline, the Norwegian Women and Cancer Study, 1996–2014
Characteristics Physical activity level at baseline (%)
1–2 3–4 5–6 7–8 9–10 Total
N = 4079 N = 19,005 N = 37,154 N = 21,819 N = 4442 N = 86,499
(4.7%) (22%) (43%) (25%) (5.1%) (100%)
Physical activity level at follow-up 47.3 41.1 41.1 41.9 45.7 36,194 (41.8)
Body mass index at baseline 2.1 2.0 1.8 1.6 2.1 1567 (1.8)
Body mass index at follow-up 42.0 37.3 37.5 38.2 40.0 32,822 (37.9)
Smoking status at follow-up 41.0 36.4 36.8 37.5 39.5 32,191 (37.2)
Number of pack-years at follow-upa 46.6 41.7 41.9 43.7 45.7 23,290 (42.1)
Duration of education (years) 6.6 5.2 4.6 4.9 6.0 4267 (4.9)
Missing in pack-year at baseline was 4 observations and is not included in the table
aNumber of pack-year only in former and current smokers at follow-up (n = 86,499)
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reduced risk of lung cancer in normal-weight and over-
weight participants with increasing PA.
The heterogeneity between studies in the relationship
between lung cancer and PA level is challenging, as the
type of PA measured, the lack of dose–response data, study
design, sex, and sample size make it difficult to compare
these studies and to calculate overall estimates. Most
studies that investigated the association between PA and
the risk of lung cancer in women focused on recreational
PA [16, 17, 36]; fewer studies have captured total PA
(including recreational, occupational, household, and
transportation) [19, 22, 37–39]. In its Second Expert Report
from 2007 to 2018, the WCRF/AICR concluded that the
evidence for an association between PA and lung cancer is
‘‘limited-suggestive’’ [11, 12]. The five cohort studies
included in that comprehensive report all had overall
summaries of PA (recreational and non-recreational), but
the lack of detail in the evidence made dose–response
analyses impossible, and only two of the studies included
women [11]. The NIH-AARP Diet and Health Study by
Leitzmann and colleagues found an inverse association
between total PA (both recreational and non-recreational)
and risk of lung cancer in analyses adjusted for sex, and
these findings were consistent in sex-specific analyses and
over other covariates, i.e. age, education level, and BMI
[22]. Our results showed a significant decreased risk of
lung cancer overall, and are thus similar to those of the
NIH-AARP Diet and Health Study; however the mea-
surements of PA between the studies are not comparable
[22]. The results of the two most recent meta-analyses on
recreational PA and risk of lung cancer showed statistically
significant, inverse associations in the range of 13–25% for
lung cancer from cohort studies [16, 17]; however these
estimates included several studies that enrolled only men.
One meta-analysis that estimated the association among
women separately found an overall relative risk of 0.73
(95% CI 0.63–0.86); however it included both case–control
and cohort studies, and the heterogeneity between the
studies was found to be high (I-squared = 50.9%) [16].
Based on cohort studies that included sex-adjusted analysis
and/or specific analysis of women, five found inverse
associations [21, 22, 40–42], while 12 others
[19, 23, 36–39, 43–49] found no association between the
risk of lung cancer and PA level (including both recre-
ational and non-recreational PA). The suggested mecha-
nisms of PA in protecting against lung cancer is through
increase in enzymatic systems that detoxify chemical car-
cinogens and in this way protect the lungs [50, 51]. In
addition, increase in antioxidants levels in PA have been
suggested to explain the protective effect of PA [49]. In a
nested case–control study within EPIC, investigating
endogenous antioxidant biomarkers in the association
Table 3 Multivariable hazard ratios and 95% confidence intervals in chained multiple imputation analyses of the association between physical
activity (PA) and lung cancer including baseline and repeated measurements in the Norwegian Women and Cancer Study (n = 86,499)
Number of lung cancer
cases
PA levels
1–2 3–4 5–6 7–8 9–10 P trend
Lung cancer overalla 866 1.73 (1.30–2.30) 1.33 (1.08–1.64) 1.00 0.84 (0.67–1.06) 0.87 (0.57–1.32) 0.000
Adenocarcinomaa 382 1.50 (0.94–2.39) 1.42 (1.06–1.90) 1.00 0.85 (0.61–1.19) 0.60 (0.27–1.31) 0.001
Squamous
carcinomasa
125 1.48 (0.71–3.11) 1.29 (0.78–2.14) 1.00 0.88 (0.47–1.66) 1.06 (0.38–2.95) 0.163
Small cella 165 1.82 (1.01–3.29) 0.93 (0.57–1.52) 1.00 0.80 (0.48–1.35) 1.16 (0.53–2.52) 0.156
Lung cancer overall stratified analyses by
Smoking Never n = 61 1.39 (0.41–4.71) 1.23 (0.63–2.42) 1.00 1.26 (0.66–2.40) 0.45 (0.06–3.34) 0.600
Former n = 140 2.34 (1.42–3.85) 1.63 (1.16–2.31) 1.00 0.96 (0.65–1.41) 1.08 (0.55–2.11) 0.000
Current n = 665 1.74 (1.29–2.33) 1.29 (1.04–1.59) 1.00 0.79 (0.61–1.01) 0.89 (0.57–1.38) 0.000
1–2 3–4 5–6 7–10 P trend
Body mass index Normal n = 608 1.60 (1.12–2.28) 1.39 (1.12–1.73) 1.00 0.84 (0.67–1.05) 0.000
Overweight n = 196 2.37 (1.54–3.63) 1.32 (0.95–1.83) 1.00 1.03 (0.71–1.50) 0.001
Obese n = 62 1.94 (0.98–3.84) 1.38 (0.75–2.52) 1.00 0.66 (0.26–1.69) 0.012
Multiple imputation of covariates in the multivariable analyses conducted with chained equation. 20 imputed data sets were generated
aModel 1: Multivariable model adjusted for body mass index, years of education, smoking status and pack-years (never; former and\ 10 pack-
years; former and C 10 pack-years; current and\ 10 pack-years; current and C 10 pack-years), fruit consumption (g/day). Model stratification
by birth cohort (strata 1: enrolled in 1996–1997 and born 1927–1942; strata 2: enrolled in 1996–1997 and born 1943–1957; and strata 3: enrolled
in 2003–2007 and born 1943–1957)
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between recreational PA and lung cancer suggesting that
PA is protective against lung cancer risk in former- and
non-smokers [49].
The investigation of the association between PA and
lung cancer is complicated by tobacco smoking, which acts
as a powerful confounder in the causation of lung cancer.
The protective association of PA observed among smokers
may be confounded by the amount and duration of cigarette
smoking [52]. The solution to this problem may be to
investigate this association among never smokers only
[23]. However, that could represent a selected group bias,
with participants who have a low prevalence of other
exposures of relevance [53]. A recent meta-analyses
stratified by smoking behavior to address this potential
bias, and concluded that PA was not related to lung cancer
in never smokers and that there was a reduced risk in
former and current smokers [52]. Our stratified analyses
indicated that the risk of lung cancer overall was reduced
among current and former smokers with increasing PA
levels. We found no significant association between lung
cancer overall and PA level in never smokers. These results
are consistent with findings from several other studies
[21–23, 38, 52, 54]. Today, there are no predominant factor
that can fully explain lung cancer in never smokers, but
risk factors considered important include second hand
smoking, radon exposure, environmental exposures, history
of lung diseases and genetic factors [55]. Further, it has
been suggested that the etiology of lung cancer among
never smokers may be distinct from that of smokers [55]
which justifies to do separate analysis by never-smokers
and ever-smokers. Therefore, the finding of no association
in the absence of cigarette smoking can be related to
residual confounding. Furthermore, the relatively low
number of lung cancer cases among never smokers made
these analyses less robust, and must therefore be inter-
preted with caution. Although we found an association
between PA and smoking in the stratified analyses the
residual confounding of smoking due to imprecisely mea-
sured smoking behavior cannot be ruled out.
The reduced risk of lung cancer was more profound
among normal-weight and overweight women with
increasing PA levels in our study. This corresponds with
findings from other studies [22, 40, 41, 54], which showed
that low and medium BMI in those with higher PA levels
reduced the risk of lung cancer. Other cohort studies
adjusted for BMI and did not report group-specific analyses
[19, 21, 23, 37–39, 48].
The strengths of our study include its prospective,
population-based design and the use of a high-quality,
national cancer registry to identify lung cancer cases [24].
The presence of repeated measurements on the exposure
and potential confounders is also a considerable strength.
This justify the importance of using repeated
measurements in our study where almost 20% of the
women changed smoking status from current to former
smokers during follow-up, despite the amount of missing
which were addressed with advanced chained multiple
imputation methods. Rubin’s rule were applied to take into
account the variability in the results using 20 imputed
datasets, to reflect the uncertainty that are associated with
missing values. The prospective design precluded bias
attributable to recall bias of PA by participants indepen-
dently of lung cancer. Moreover, the PA scale we used has
been validated [26] and correlated well with all-cause
mortality rates [56]. Our assessment of PA in the NOWAC
Study comprised total PA, covering the domains of recre-
ation, occupation, household and transportation, with one
repeated measurement during follow-up. We chose to
impute missing information at baseline and follow-up,
assuming a missing-at-random framework. Our chained
imputation models included all variables for the final Cox
proportional hazards regression models and additional
variables in order to predict incomplete variables or to
predict whether the incomplete variable was missing [57].
This method has been developed and proved robust in
several of studies within the NOWAC study [31–33, 58],
and the consistency with the complete-case analysis
strengthens the results. Nevertheless, we cannot rule out
that some of the information is still missing-not-at-random
which may lead to biased estimations. Our large prospec-
tive study included a high number of lung cancer cases, and
thus it was possible to investigate histological subtypes. In
Norway the mean age at smoking initiation has been found
to be B 20 years [7, 59]. The 30-year lag period between
smoking initiation and time of cohort enrollment (mean age
52 years) for the majority of smokers gives an increased
risk of lung cancer. The follow-up time (13 years) in our
study adds to this, justifying a relatively long follow-up.
The total self-reported measure of PA in the NOWAC
Study cannot differentiate intensity, duration, and fre-
quency of PA, nor the type of PA, and given the self-
reported nature of this variable, measurement errors cannot
be ruled out. A known problem in self-reporting of a
desirable behaviour like PA is the tendency to overesti-
mate; i.e. report levels that are higher than one really has
[60, 61]. However, measurement errors would likely lead
to a non-differential bias in relation to the cancer versus
non-cancer status and a potential underestimation of the
true effect. The PA assessment used in this study may not
apply to women in other countries, and the scale cannot
directly be compared to other studies using a different
measure of PA. Moreover, the potential for residual con-
founding, in particular by lifetime smoking habits (i.e. age
at initiation, time since quitting for former smokers, type of
cigarettes smoked and passive smoking), is a recurrent
problem in studies of lung cancer and is possible affecting
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our results. In particular, the PA measurement could
introduce information bias, together with other risk factors
that were not measured; i.e. second-hand smoking and
radon exposure. Certain other lifestyle-related factors may
act as confounders or effect-modifiers and cannot be
excluded.
Conclusions
In this study we used a large nationally representative and
prospective cohort and presented analyses using time
varying covariates and dealt with attrition using chained
multiple imputations. We found that higher PA was asso-
ciated with lower risk of lung cancer overall and no asso-
ciation among never smokers. Women who were within the
normal- and overweight range appeared to benefit from a
higher protective effect of PA, as did those who were
current and former smokers. However, the findings must be
interpreted with caution as residual confounding by
smoking behavior cannot be ruled out. The continuing
increase in lung cancer among women in Norway, as well
as in a numerous of countries may foreshadow a higher
future burden of lung cancer in women than previously
expected. Thus, there is a need to intensify anti-tobacco
measures to decrease smoking in women. To promote
smoking cessation and prevent people to start smoking is
the primary means of preventing lung cancer. Furthermore,
to prevent lung cancer in all groups of the population
independently of their smoking status through a modifiable
lifestyle factor as PA is of tremendous interest in the field
of public health.
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